Literature DB >> 17456038

Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential.

Silvana Marcussi1, Carolina D Sant'Ana, Clayton Z Oliveira, Aristides Quintero Rueda, Danilo L Menaldo, Rene O Beleboni, Rodrigo G Stabeli, José R Giglio, Marcos R M Fontes, Andreimar M Soares.   

Abstract

Phospholipases A2 (PLA2s) are commonly found in snake venoms from Viperidae, Hydrophidae and Elaphidae families and have been extensively studied due to their pharmacological and physiopathological effects in living organisms. This article reports a review on natural and artificial inhibitors of enzymatic, toxic and pharmacological effects induced by snake venom PLA2s. These inhibitors act on PLA2s through different mechanisms, most of them still not completely understood, including binding to specific domains, denaturation, modification of specific amino acid residues and others. Several substances have been evaluated regarding their effects against snake venoms and isolated toxins, including plant extracts and compounds from marine animals, mammals and snakes serum plasma, in addition to poly or monoclonal antibodies and several synthetic molecules. Research involving these inhibitors may be useful to understand the mechanism of action of PLA2s and their role in envenomations caused by snake bite. Furthermore, the biotechnological potential of PLA2 inhibitors may provide therapeutic molecular models with antiophidian activity to supplement the conventional serum therapy against these multifunctional enzymes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456038     DOI: 10.2174/156802607780487614

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  23 in total

1.  Molecular docking and dynamic studies of crepiside E beta glucopyranoside as an inhibitor of snake venom PLA2.

Authors:  Mala S Kumar; Amjesh R; Silpa Bhaskaran; Delphin R D; Achuthsankar S Nair; Sudhakaran P R
Journal:  J Mol Model       Date:  2019-03-08       Impact factor: 1.810

2.  Hemorrhagic changes and microglia activation induced by Macrovipera lebetina obtusa venom with the inhibited enzymatic activity in rat brain.

Authors:  Armen V Voskanyan; Anna A Darbinyan; Lilya M Parseghyan
Journal:  Toxicol Res       Date:  2021-07-02

Review 3.  Therapeutic potential of snake venom in cancer therapy: current perspectives.

Authors:  Vivek Kumar Vyas; Keyur Brahmbhatt; Hardik Bhatt; Utsav Parmar
Journal:  Asian Pac J Trop Biomed       Date:  2013-02

Review 4.  Inhibition of hemorragic snake venom components: old and new approaches.

Authors:  Isabella Panfoli; Daniela Calzia; Silvia Ravera; Alessandro Morelli
Journal:  Toxins (Basel)       Date:  2010-03-25       Impact factor: 4.546

5.  Therapeutic application of natural inhibitors against snake venom phospholipase A(2).

Authors:  Ramar Perumal Samy; Ponnampalam Gopalakrishnakone; Vincent Tk Chow
Journal:  Bioinformation       Date:  2012-01-06

6.  Structural and functional studies of a bothropic myotoxin complexed to rosmarinic acid: new insights into Lys49-PLA₂ inhibition.

Authors:  Juliana I Dos Santos; Fábio F Cardoso; Andreimar M Soares; Maeli Dal Pai Silva; Márcia Gallacci; Marcos R M Fontes
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

7.  A RNA-seq approach to identify putative toxins from acrorhagi in aggressive and non-aggressive Anthopleura elegantissima polyps.

Authors:  Jason Macrander; Mercer R Brugler; Marymegan Daly
Journal:  BMC Genomics       Date:  2015-03-21       Impact factor: 3.969

8.  A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A2.

Authors:  Nirvanappa C Anilkumar; Mahalingam S Sundaram; Chakrabhavi Dhananjaya Mohan; Shobith Rangappa; Krishna C Bulusu; Julian E Fuchs; Kesturu S Girish; Andreas Bender; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

Review 9.  Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules.

Authors:  B M A Carvalho; J D L Santos; B M Xavier; J R Almeida; L M Resende; W Martins; S Marcussi; S Marangoni; R G Stábeli; L A Calderon; A M Soares; S L Da Silva; D P Marchi-Salvador
Journal:  Biomed Res Int       Date:  2013-09-22       Impact factor: 3.411

10.  In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Authors:  G Sakthivel; Amitabha Dey; Kh Nongalleima; Murthy Chavali; R S Rimal Isaac; N Surjit Singh; Lokesh Deb
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.